Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Serious side effects like pancreatitis are uncommon in medical supervision settings, and PlexusDx providers screen for risk factors before prescribing
After propensity score matching against multiple antidiabetic drug classes (insulin, metformin, SGLT-2 inhibitors, DPP-4 inhibitors, sulfonylureas), results showed: No significant increase in thyroid cancer incidence Median follow-up of ~4.5 years Risk estimates comparable or lower than other glucose-lowering therapies Overall, current epidemiological evidence does not support a clinically meaningful increase in thyroid cancer risk in humans
L.Carmo-RodriguesM
The ARC receives inputs from numerous divergent sources
US$ 28.10
US$ 24.38
US$ 22.45
US$ 27.66
US$ 23.64
US$ 20.69
US$ 20.33
US$ 28.10
